CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 167975-168115 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/038354e8830fe01feb621a12e8a8c467a15b6354","sourcedb":"CORD-19","sourceid":"038354e8830fe01feb621a12e8a8c467a15b6354","text":"Two specific inhibitors of influenza A and B neuraminidase are currently available for clinical use: inhaled zanamivir and oral oseltamivir.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1050","span":{"begin":0,"end":140},"obj":"Sentence"},{"id":"T40212","span":{"begin":0,"end":140},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T1050","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T40212","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T118","span":{"begin":0,"end":140},"obj":"Sentence"}],"attributes":[{"subj":"T118","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T888","span":{"begin":27,"end":36},"obj":"Disease"}],"attributes":[{"id":"A888","pred":"mondo_id","subj":"T888","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"subj":"T888","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ecd393","default":true},{"id":"CORD-19_Custom_license_subset","color":"#b993ec"},{"id":"CORD-19-PD-MONDO","color":"#93ec9f"}]}]}}